• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2400487 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2024-05-14 Zhejiang Heze Pharmaceutical Technology Co Ltd view
JYSB2400059 利拉鲁肽注射液 liraglutide Injection Biological Products Supplementary Application 2024-03-14 Novo Nordisk A/S view
JYSB2400035 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Supplementary Application 2024-02-27 Novo Nordisk A/S view
CXSL2400105 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-07 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2400082 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-01 view
JYSB2400021 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2024-02-01 view
JYSB2400017 利拉鲁肽注射液 liraglutide Injection Biological Products Supplementary Application 2024-01-30 view
JYSZ2300038 利拉鲁肽注射液 liraglutide Injection Biological Products License Renew 2023-09-13 view
CXSS2300067 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2023-08-22 view
CXSL2300515 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-07-26 Jilin Huisheng Biopharmaceutical Co Ltd view
CXHL2300222 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2023-02-15 Zhejiang Heze Pharmaceutical Technology Co Ltd view
CXHL2300221 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2023-02-15 Zhejiang Heze Pharmaceutical Technology Co Ltd view
CXSL2300092 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-02-08 Federal Biotechnology (Zhuhai Hengqin) Co Ltd view
CYSB2300007 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2023-01-11 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CXSS2200085 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2022-10-21 view
CXSL2200411 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2022-08-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CXHS2200041 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2022-07-28 Hybio Pharmaceutical Co Ltd view
CXSS2200064 利拉鲁肽注射液 liraglutide Injection Biological Products(3.2) New Drug Application 2022-07-14 view
CXSS2200065 利拉鲁肽注射液 liraglutide Injection Biological Products(3.2) New Drug Application 2022-07-14 view
CXSS2200058 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2022-06-09 Tonghua Dongbao Pharmaceutical Co Ltd view